Associations of Whole Blood n-3 and n-6 Polyunsaturated Fatty Acids with Blood Pressure in Children and Adolescents - Results from the IDEFICS/I.Family Cohort

PLoS One. 2016 Nov 2;11(11):e0165981. doi: 10.1371/journal.pone.0165981. eCollection 2016.

Abstract

Background: Polyunsaturated n-3 and n-6 polyunsaturated fatty acids (PUFA) are precursors of biologically active metabolites that affect blood pressure (BP) regulation. This study investigated the association of n-3 and n-6 PUFA and BP in children and adolescents.

Methods: In a subsample of 1267 children aged 2-9 years at baseline of the European IDEFICS (Identification and prevention of dietary- and lifestyle-induced health effects in children and infants) cohort whole blood fatty acids were measured by a validated gas chromatographic method. Systolic and diastolic BP was measured at baseline and after two and six years. Mixed-effects models were used to assess the associations between fatty acids at baseline and BP z-scores over time adjusting for relevant covariables. Models were further estimated stratified by sex and weight status.

Results: The baseline level of arachidonic acid was positively associated with subsequent systolic BP (β = 0.08, P = 0.002) and diastolic BP (β = 0.07, P<0.001). In thin/normal weight children, baseline alpha-linolenic (β = -1.13, P = 0.003) and eicosapentaenoic acid (β = -0.85, P = 0.003) levels were inversely related to baseline and also to subsequent systolic BP and alpha-linolenic acid to subsequent diastolic BP. In overweight/obese children, baseline eicosapentaenoic acid level was positively associated with baseline diastolic BP (β = 0.54, P = 0.005).

Conclusions: Low blood arachidonic acid levels in the whole sample and high n-3 PUFA levels in thin/normal weight children are associated with lower and therefore healthier BP. The beneficial effects of high n-3 PUFA on BP were not observed in overweight/obese children, suggesting that they may have been overlaid by the unfavorable effects of excess weight.

MeSH terms

  • Adolescent
  • Arachidonic Acid / blood*
  • Blood Pressure*
  • Body Weight
  • Child
  • Child, Preschool
  • Chromatography, Gas
  • Cohort Studies
  • Eicosapentaenoic Acid / blood
  • Fatty Acids, Omega-3 / blood*
  • Fatty Acids, Omega-6 / blood*
  • Female
  • Humans
  • Male
  • Obesity / metabolism*
  • alpha-Linolenic Acid / blood

Substances

  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • alpha-Linolenic Acid
  • Arachidonic Acid
  • Eicosapentaenoic Acid

Grant support

The baseline data collection and the first follow-up work as part of the IDEFICS Study (www.idefics.eu) were financially supported by the European Commission within the Sixth RTD Framework Programme Contract No. 016181 (FOOD). The most recent follow-up was conducted in the framework of the I.Family study (www.ifamilystudy.eu/) which was funded by the European Commission within the Seventh RTD Framework Programme Contract No. FP7 266044 (KBBE 2010-4).